Background: As a substudy of the large, randomized LONG-DES-III and IV (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III and IV) trials comparing sirolimus-eluting stents (SES), everolimus-eluting stents (EES) and zotarolimus-eluting stents (ZES), we sought to investigate intimal hyperplasia (IH) and vascular changes using volumetric intravascular ultrasound analysis Methods: Complete angiographic and volumetric intravascular ultrasound data immediately after stenting and at 9-month follow-up were available in 259 patients with 259 lesions (130 SES, 61 EES and 68 ZES). External elastic membrane (EEM), stent, lumen, and peristent plaque volumes (external elastic membrane minus stent) were normalized by stent length. Results: Normalized IH volume was greater in EES than SES (0.7Ϯ0.4 mm 2 vs. 0.5Ϯ0.4 mm 2 , P Ͻ0.05), whereas normalized IH volume in ZES was similar to those in SES (0.5Ϯ0.4 mm 2 vs. 0.5Ϯ0.4 mm 2 ). Change in normalized EEM volume was smaller in EES than in SES (0.1Ϯ 1.2 mm 2 vs. 0.6Ϯ1.5 mm 2 , PϽ0.05). However, the changes in normalized EEM volume were not different between ZES vs. SES (0.6 Ϯ1.5 mm 2 vs. 0.6 Ϯ1.1 mm 2 ). Late stent malapposition was identified in 7 (5%) SES and 1 (1%) ZES, there was no EES lesion with malapposition. Conclusions: In the coronary lesions with long stent length, the degree of neointimal growth in ZES was similar to SES, but less than that in EES. Expansive vascular remodeling in ZES was comparable to SES, but greater than EES.
Background: Percutaneous coronary intervention carries a risk of dissections at the edges of the implanted stent. Optical coherence tomography (OCT) enables detection and detailed characterization of edge dissections (ED). We investigated the incidence, predictors and outcome of OCT detected EDs. Methods: All patients with OCT evaluation at baseline and 12-month follow-up (FU) in the SORT-OUT V OCT substudy were included in the analysis. Plaques present in the edge segments 5 mm proximal and distal to the study stent were characterized by plaque type. All EDs were characterized by size and underlying plaque type. Results: A total of 123 patients were included in the OCT substudy. Of these, 23 were not available for analysis due to patient drop out, contraindication to the FU OCT or poor image quality. No baseline EDs were found in three coronary event patients with no OCT FU. One patient with stent thrombosis (ST) within 2 hours had ED in a fibroatheroma. In the 97 patients included in the analysis 177 edges were visualized by OCT. A total of 37 (20.1%) EDs were detected in 33 patients (34% of patients 
